Drug Screening Market - Top Companies and Manufacturers

  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Drug Screening Landscape

    • Quest Diagnostics
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Laboratory Corporation of America Holdings (LabCorp)
    • Thermo Fisher Scientific
    • Alere Inc.
    • Siemens Healthineers
    • Shimadzu Corporation
    • F. Hoffmann-La Roche AG
    • Express Diagnostics International Inc.
    • OraSure Technologies
    • Drägerwerk AG & Co. KGaA

Browse Key Market Insights with Data Illustration:

In the News

  • Quest Diagnostics: Quest Diagnostics announced that it had received emergency use authorization from the U.S. Food and Drug Administration (FDA) for a new test that can detect the Omicron variant of the COVID-19 virus. The test is called the "Quest SARS-CoV-2 RT-PCR test for the detection of the Omicron variant" and is designed to be used with respiratory specimens.
  • Thermo Fisher Scientific: Thermo Fisher Scientific announced that it had completed the acquisition of PPD, a leading global contract research organization (CRO). The acquisition will expand Thermo Fisher's capabilities in clinical research services and strengthen its position in the healthcare and life sciences markets. The acquisition was valued at USD 27.2 billion and is one of the largest in the history of the healthcare industry.

Author Credits:  Radhika Pawar


  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The drug screening market size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of drug abuse, and stringent government regulations will boost the market growth.

Asia Pacific industry is set to hold 24% of the revenue share till 2037, impelled by rising awareness about drug screening in the region.

The major players in the market include Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, Alere Inc., Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample